Diisopropylcarbodiimide → N-alpha-Benzyloxycarbonyl-L-lysine

HRID 916522

Reaktionsgleichung

Reaktionsgleichung von HRID 916522
[C:1]([N:11](C(OCC1C=CC=CC=1)=O)[C@H:12]([C:18]([OH:20])=[O:19])[CH2:13][CH2:14][CH2:15][CH2:16][NH2:17])([O:3][CH2:4][C:5]1[CH:10]=[CH:9][CH:8]=[CH:7][CH:6]=1)=[O:2].CC(C)N=C=NC(C)C.CC[C@@]1(O)C(=O)OCC2C(N3C(=CC1=2)C1N=C2C(C=CC=C2)=CC=1C3)=O>C(Cl)Cl.CN(C1C=CN=CC=1)C>[NH:11]([C:1]([O:3][CH2:4][C:5]1[CH:6]=[CH:7][CH:8]=[CH:9][CH:10]=1)=[O:2])[C@H:12]([C:18]([OH:20])=[O:19])[CH2:13][CH2:14][CH2:15][CH2:16][NH2:17]

Komponenten

6

Edukt 3

HCID 12734DiisopropylcarbodiimideHCID 24360CamptothecinHCID 18595285Dicarbobenzoxy-l-lysine

Produkt 1

HCID 75172N-alpha-Benzyloxycarbonyl-L-lysine

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 142844-(Dimethylamino)pyridineKatalysatorHCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

N,N-Bis CBZ-Lysine (311 mg, 0.75 mmol) was dissolved in 56 mL of anhydrous methylene chloride at room temperature. To this solution were added DIPC (0.12 mL, 0.75 mmol), DMAP (0.61 mg, 0.5 mmol) and camptothecin (0.087 g, 0.25 mmol) at 0° C. The reaction mixture was allowed to warm to room temperature and left for 16 h. The solution was washed with 0.1 N HCl, dried and evaporated under reduced pressure to yield a light yellow solid, which was recrystallized from methanol to give camptothecin-20-ester of N,N-Bis CBZ-Lys 13. Purification of 13 was satisfactory based on TLC and HPLC analysis.

Aufarbeitung

  1. washThe solution was washed with 0.1 N HCl
  2. customdried
  3. customevaporated under reduced pressure
  4. customto yield a light yellow solid, which
  5. customwas recrystallized from methanol

Quellen und Nachweise

ORD-Eintrag
ord-b4763f1fae70488594e09ba58e389690
Quelldatensatz
uspto-grants-2007_09
Patentnummer
US07270808B2

Verknüpfte Notizen

Wird geladen…